Page 7 - Jay Flatley News Today

EMERYVILLE, Calif., March 22, 2022 -- Biotechnology company Zymergen Inc. , today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021. ... | March 22, 2022

In this article, we discuss the 5 stocks that Cathie Wood is doubling down on despite losses.

Delivering platform expertise and developing novel microbes, molecules and materials for customers across a variety of markets...

In this article, we discuss the 10 best biotech stocks under $20 in Cathie Woods portfolio.

An insider didn't wait for Black Friday to make a large purchase of this synbio stock.

ZY earnings call for the period ending September 30, 2021.

David Cameron, a paid adviser for US biotech gene-sequencing company Illumina, told Matt Hancock he strongly endorsed the firms invitation to the then-Health Secretary in April 2019.

By Ari Levy, CNBC • Updated 5 hours ago Mark Neuling | CNBC Zymergen went public at $31 a share in April and traded as high as $48.50, valuing the company at $4.8 billion. The stock sank to $11.07 after hours on Tuesday, leaving its market cap at just over $1 billion. The company has yet to start generating product sales and said it now expects revenue from its products to be "immaterial" through 2022. A little more than three months after pricing its IPO at the top of its expecte...

By Ari Levy, CNBC • Updated on August 3, 2021 at 8:15 pm Mark Neuling | CNBC Zymergen went public at $31 a share in April and traded as high as $48.50, valuing the company at $4.8 billion. The stock sank to $11.07 after hours on Tuesday, leaving its market cap at just over $1 billion. The company has yet to start generating product sales and said it now expects revenue from its products to be "immaterial" through 2022. A little more than three months after pricing its IPO at the t...

Zymergen Provides Business Update Zymergen Inc. Jay Flatley, Chairman of the Board, Appointed Acting CEO; Josh Hoffman to Step Down Conference Call to be Held at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Today EMERYVILLE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today provided a business update regarding its commercial product pipeline and financial forecast. Zymergen recently became aware of issues with its commercial product pi...